Therapy: Risks associated with chronic PPI use - signal or noise?
about
Proton Pump Inhibitors in Gastroesophageal Reflux Disease: Friend or Foe.ACG and CAG Clinical Guideline: Management of Dyspepsia.When is proton pump inhibitor use appropriate?Emerging dilemmas in the diagnosis and management of gastroesophageal reflux disease.Abnormal esophageal acid exposure on high-dose proton pump inhibitor therapy is common in systemic sclerosis patients.Maintenance use of non-steroidal anti-inflammatory drugs and risk of gastrointestinal cancer in a nationwide population-based cohort study in Sweden.
P2860
Therapy: Risks associated with chronic PPI use - signal or noise?
description
2016 nî lūn-bûn
@nan
2016 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մարտին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Therapy: Risks associated with chronic PPI use - signal or noise?
@ast
Therapy: Risks associated with chronic PPI use - signal or noise?
@en
Therapy: Risks associated with chronic PPI use - signal or noise?
@nl
type
label
Therapy: Risks associated with chronic PPI use - signal or noise?
@ast
Therapy: Risks associated with chronic PPI use - signal or noise?
@en
Therapy: Risks associated with chronic PPI use - signal or noise?
@nl
prefLabel
Therapy: Risks associated with chronic PPI use - signal or noise?
@ast
Therapy: Risks associated with chronic PPI use - signal or noise?
@en
Therapy: Risks associated with chronic PPI use - signal or noise?
@nl
P2860
P356
P1476
Therapy: Risks associated with chronic PPI use - signal or noise?
@en
P2093
Peter J Kahrilas
P2860
P2888
P304
P356
10.1038/NRGASTRO.2016.44
P407
P577
2016-03-16T00:00:00Z
P6179
1003441522